EXOSOMM

EXOSOMM Overview

EXOSOMM is the first and only company in the world to produce "active milk exosomes" at an "industrial scale, with a shelf life exceeding one year. Our proprietary, patent-protected process sustainably isolates exosomes from cow milk whey—a dairy side-stream—without the use of chemicals, transforming waste into high-value therapeutic solutions for inflammatory diseases. What Are Milk Exosomes? Exosomes are nano-sized vesicles that carry microRNAs, proteins, and lipids, acting as messengers for cellular communication. In milk, these exosomes are naturally bioavailable, surviving digestion and delivering bioactive signals that support immune regulation, gut health, and systemic anti-inflammatory responses. Why Aren’t Milk Exosomes Commercially Available? Despite their immense therapeutic potential, milk exosomes have remained inaccessible at scale due to the complexity of isolating them without damaging their structure or function. Until now, no company has succeeded in developing a scalable, shelf-stable, and biologically active milk exosome product—making EXOSOMM a global first. Manufacturing & Sustainability Highlights - Industrial production capacity: 200 metric tons annually - Chemical-free isolation from cow milk whey - Upcycling dairy waste aligns with ESG goals and reduces input costs - Circular economy model: converting low-value by-products into high-impact bioactives Traction & Strategic Partnerships - Clalit Health Services: Israel’s largest HMO - Tnuva: Israel’s largest food conglomerate - Baemek: Tnuva’s manufacturing facility - Hadassah Medical Center: Completed first-in-human clinical trial - Backed by leading VCs: SOSV, Siddhi Capital, AgFunder - GRAS -Generally Recognized as Safe, regulatory clearance for supplement and food ingredient use

Cumulative Funding Raised Over Time ($)

Latest News

Apr 29, 2025 · www.linkedin.com

growth-positive

EXOSOMM in the Top 10 FoodTech World Cup Finalists 🥁

The article announces the Top 10 finalists of the FoodTech World Cup, highlighting innovative startups in the food for health sector. Among the finalists is Antithesis Foods Inc., a U.S.-based company that creates healthy snacks using patent-pending food science, funded by the National Science Foundation. Other finalists include companies from Singapore, Israel, Argentina, Sweden, Germany, and Brazil, each focusing on unique innovations such as fortified chocolates, bioactive supplements, sustainable fats, and more. The event is supported by notable partners like Givaudan and Nestlé Research & Development Lausanne. The competition showcases the global effort to enhance food technology and health through innovative solutions.

Nov 21, 2023 · www.israel21c.org

growth-positive

Milk extract could ease symptoms of Crohn's and colitis - ISRAEL21c

Exosomm, an Israeli biotech startup, is preparing for clinical trials of a natural supplement derived from cow milk to treat inflammatory bowel diseases like Crohn’s and colitis. The company has developed a method to extract exosomes from cow milk, which are similar to those found in human milk and have anti-inflammatory properties. These exosomes will be added to food products like yogurt and milkshake powders. The initial clinical trial will involve 30 healthy individuals and will be conducted in collaboration with Hadassah Medical Center. Exosomm has partnered with Tnuva, Israels largest food company, to extract exosomes from dairy milk processed in Tnuva plants. The company aims to make the product available by early 2025.

Product StagePartners

Sep 6, 2023 · wired.me

growth-positive

By leveraging its scientific research, EXOSOMM has devised a futuristic technique capable of extracting exosomes, which are naturally occurring particles found in maternal milk

Remilk, a Tel Aviv-based foodtech startup, is pioneering lab-grown dairy production using precision fermentation. This method allows for the creation of dairy proteins without traditional animal agriculture, offering a sustainable and ethical alternative. Remilk has received approval from the Israeli government and raised significant investment, including $120 million last year. The company is part of a broader movement in the Middle East to innovate in the dairy sector, with partnerships and investments from global giants like Danone and Unilever. The technology promises to reduce environmental impact and enhance food security in the region.

Product StageInvestmentPartners

May 16, 2023 · www.dairyreporter.com

growth-positive

Exosomm upcycles cheese by-products to derive a 'potent functional ingredient'

Exosomm, an Israeli foodtech start-up, has developed a method to isolate exosomes from upcycled whey, a byproduct of cheese production, to create a bioactive ingredient aimed at managing chronic metabolic disorders. The technology, developed at Hadassah University Medical Center, is now ready for commercial scaling. Exosomm collaborates with Ba’emek Tech for whey supply and infrastructure. The company has received $1 million in pre-seed investment from the Ofek-Galil incubator. Exosomms exosomes have shown promise in preclinical studies for reducing inflammation in IBD patients and improving glucose tolerance. The start-up is targeting the medical food space and plans further clinical research.

Product StagePartnersInvestment

May 15, 2023 · www.dairyreporter.com

growth-positive

Exosomm upcycles cheese by-products to derive a 'potent functional ingredient'

Exosomm, Ltd. is a company that specializes in utilizing exosomes, nano-sized particles found in breastmilk, for managing immune-related disorders in adults. The company has developed a technology to isolate exosomes from byproducts of the cheesemaking process. They have collaborated with Ba’emek Tech, a dairy food producer, to scale up production. Exosomm aims to target the medical food space and develop food formulas for consumers with special dietary requirements. The company has received $1 million in pre-seed investment from Ofek-Galil incubator. Their research has shown promising results in reducing inflammation and improving glucose tolerance in preclinical studies. The founders of Exosomm have extensive experience in the medical and food industries.

InvestmentExpand

Funding

Team Members

8

Employees: 1-10

Web & Social Links

Locations

Haifa, Israel

Photos & Videos

1 item(s)

EXOSOMM Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info